標題: | Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment |
作者: | Georghiou, Sophia B. Rodwell, Timothy C. Korobitsyn, Alexei Abbadi, Said H. Ajbani, Kanchan Alffenaar, Jan Willem Alland, David Alvarez, Nataly Andres, Sönke Ardizzoni, Elisa Aubry, Alexandra Baldan, Rossella Ballif, Marie Barilar, Ivan Böttger, Erik C. Chakravorty, Soumitesh Claxton, Pauline M. Cirillo, Daniela M. Comas, Iñaki Coulter, Chris Denkinger, Claudia M. Derendinger, Brigitta Desmond, Edward P. de Steenwinkel, Jurriaan E.M. Dheda, Keertan Diacon, Andreas H. Dolinger, David L. Dooley, Kelly E. Egger, Matthias Ehsani, Soudeh Farhat, Maha R. Fattorini, Lanfranco Finci, Iris Le Ray, Laure Fournier Furió, Victoria Groenheit, Ramona Gumbo, Tawanda Heysell, Scott K. Hillemann, Doris Hoffmann, Harald PO-REN HSUEH Hu, Yi Huang, Hairong Hussain, Alamdar Ismail, Farzana Izumi, Kiyohiko Jagielski, Tomasz Johnson, John L. Kambli, Priti Kaniga, Koné Eranga Karunaratne, G. H.R. Sharma, Meenu Kaushal Keller, Peter M. Kelly, Ellis C. Kholina, Margarita Kohli, Mikashmi Kranzer, Katharina Laurenson, Ian F. Limberis, Jason Grace Lin, S. Y. Liu, Yongge López-Gavín, Alexandre Lyander, Anna Machado, Diana Martinez, Elena Masood, Faisal Mitarai, Satoshi Mvelase, Nomonde R. Niemann, Stefan Nikolayevskyy, Vladyslav Maurer, Florian P. Merker, Matthias Miotto, Paolo Omar, Shaheed V. Otto-Knapp, Ralf Palaci, Moisés Gutiérrez, Juan José Palacios Peacock, Sharon J. Peloquin, Charles A. Perera, Jennifer Pierre-Audigier, Catherine Pholwat, Suporn Posey, James E. Prammananan, Therdsak Rigouts, Leen Robledo, Jaime Rockwood, Neesha Rodrigues, Camilla Salfinger, Max Schechter, Marcos C. Seifert, Marva Sengstake, Sarah Shinnick, Thomas Shubladze, Natalia Sintchenko, Vitali Sirgel, Frederick Somasundaram, Sulochana Sterling, Timothy R. Spitaleri, Andrea Streicher, Elizabeth |
公開日期: | 四月-2022 |
卷: | 59 |
期: | 4 |
來源出版物: | The European respiratory journal |
摘要: | Inappropriately high breakpoints have resulted in systematic false-susceptible AST results to anti-TB drugs. MIC, PK/PD and clinical outcome data should be combined when setting breakpoints to minimise the emergence and spread of antimicrobial resistance. https://bit.ly/3i43wb6 |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/637171 |
ISSN: | 09031936 |
DOI: | 10.1183/13993003.00166-2022 |
顯示於: | 醫學院附設醫院 (臺大醫院)
|